World J Gastroenterol10 Sep 2025
Laparoscopic transcystic common bile duct exploration (LTCBDE) achieves a 71.1% textbook outcome rate, defined by seven key criteria including postoperative complications and length of stay. Researchers identified major risk factors for failure: delayed drainage removal and prolonged hospitalization. Preoperative endoscopic retrograde cholangiopancreatography emerged as a…
Surg Endosc9 Sep 2025
A novel pancreatic head clockwise devascularization approach during robotic pancreaticoduodenectomy significantly reduced operation time and blood loss compared to the traditional superior mesenteric artery-first method. Surgery duration dropped to 616 minutes with only 50 ml of blood loss, while the conventional method saw 772 minutes…
Surg Endosc9 Sep 2025
A new anatomical landmark, the perinephric vein, enhances access to the left renal vein during minimally invasive distal pancreatectomy (MIDP) for pancreatic cancer. In a cohort of 114 patients, 63.2% with pancreatic ductal adenocarcinoma showed the vein could help secure the posterior surgical margin, improving…
JAMA Netw Open8 Sep 2025
Dynamic prognostic models for colorectal cancer with liver metastases significantly enhance survival predictions by integrating longitudinal laboratory markers. In a cohort of 976 patients, the most effective model outperformed static approaches, achieving area under the curve (AUC) values of 0.850 for five-year progression-free survival and…
JAMA Surg7 Sep 2025
A 6-week multimodal prehabilitation program significantly slashed postoperative morbidity in patients with sarcopenia undergoing major hepatectomy. The prehabilitation group experienced a mere 13.3% complication rate compared to 50% in the standard care arm, translating to a 36.7% absolute risk reduction. All major complications occurred in…
J Surg Oncol6 Sep 2025
Conversion therapy (CT) significantly improves overall and progression-free survival in patients with locally advanced intrahepatic cholangiocarcinoma (LA-ICCA). In a retrospective analysis of 115 patients, median overall survival reached 45.53 months and progression-free survival was 18.23 months post-propensity score matching, both superior to systemic therapy (ST)…
Ann Med Surg (Lond)6 Sep 2025
The burden of liver cancer in Europe has escalated significantly from 1990 to 2021, with age-standardized incidence rising from 3.04 to 4.20 per 100,000. Males experienced disproportionately higher rates, particularly in older populations. Key risk factors include hepatitis C, alcohol consumption, and nonalcoholic steatohepatitis, with…
Int J Surg Case Rep6 Sep 2025
A modified Appleby procedure successfully treated a pancreatic body tumor encasing the celiac axis, previously deemed inoperable. Utilizing a replaced left hepatic artery, surgeons safeguarded gastric and hepatic perfusion during the distal pancreatectomy and en bloc celiac axis resection. This rare vascular variant opened new…
Ann Surg5 Sep 2025
A novel perineural invasion (PNI) severity score effectively predicts disease recurrence and survival in resected pancreatic ductal adenocarcinoma. Among 300 patients, PNI severity correlated with worse pathological outcomes: shorter recurrence times (24 months for PNI 0 vs. 15 months for PNI 2) and reduced survival…
J Surg Res4 Sep 2025
A novel training model utilizing deceased donor pancreata significantly boosts surgical residents' skills in pancreaticojejunostomy. Nearly 87% of participants reported increased confidence, while over 82% noted enhancements in anastomotic technique and execution. Faculty assert that inadequate exposure hinders residents’ participation, but access to this training…